Brief: Sinopharm Reports Qtrly Profit Attributable RMB1.43 Billion
April 22 (Reuters) - Sinopharm Group Co Ltd 1099.HK :
* QTRLY PROFIT ATTRIBUTABLE RMB1.43 BILLION VERSUS RMB1.22
BILLION
* QTRLY TOTAL OPERATING REVENUE RMB127.60 BILLION VERSUS
RMB120.27
BILLION
Source text for Eikon: ID:nHKS1gFrQC
Further company coverage: 1099.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For